Tuberculosis care among refugees arriving in Europe: a ERS/WHO Europe Region survey of current practices

Eur Respir J. 2016 Sep;48(3):808-17. doi: 10.1183/13993003.00840-2016. Epub 2016 Aug 4.

Abstract

No evidence exists on tuberculosis (TB) and latent TB infection (LTBI) management policies among refugees in European countries.A questionnaire investigating screening and management practices among refugees was sent to 38 national TB programme representatives of low and intermediate TB incidence European countries/territories of the WHO European Region.Out of 36 responding countries, 31 (86.1%) reported screening for active TB, 19 for LTBI, and eight (22.2%) reporting outcomes of LTBI treatment. Screening for TB is based on algorithms including different combinations of symptom-based questionnaires, bacteriology and chest radiography and LTBI screening on different combinations of tuberculin skin test and interferon-γ release assays. In 22 (61.1%) countries, TB and LTBI screening are performed in refugee centres. In 22 (61.1%) countries, TB services are organised in collaboration with the private sector. 27 (75%) countries answered that screening for TB is performed as per national and international guidelines, while 19 (52.7%) gave the same answer with regards to LTBI screening. Infection control measures are inadequate in several of the countries surveyed.There is need for improved coordination of TB screening in Europe to implement the End TB Strategy and achieve TB elimination.

MeSH terms

  • Algorithms
  • Communicable Disease Control
  • Europe
  • Humans
  • Incidence
  • Interferon-gamma Release Tests*
  • Latent Tuberculosis / diagnosis
  • Mass Screening
  • Practice Guidelines as Topic
  • Refugees*
  • Surveys and Questionnaires
  • Transients and Migrants
  • Tuberculin Test
  • Tuberculosis / diagnosis
  • Tuberculosis / epidemiology*
  • Tuberculosis / therapy*
  • World Health Organization